Skip to content

Clinical trials

Overweight trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Hungary Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20172
20182
20211
20221
20233
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed8
Active, not recruiting4
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S9
Eli Lilly and Company5
Amgen4
AstraZeneca1
Federico II University1
Gelesis, Inc.1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
Semmelweis University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight24
Obesity23
Diabetes Mellitus, Type 27
Diabetes Mellitus2
Sleep Apnea, Obstructive2
Aortic Coarctation1
Aortic Valve Stenosis1
Atherosclerosis1
Colitis, Ulcerative1
Crohn Disease1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.